Hov, regardless of the technology is legit or not, what realistic options does the comapany have left in order to survive. It’s mind boggling what’s happened to the SP. it will take more than a miracle to right this ship, or so it seems.
Hov is your investment thesis that the technology has not been proven to be a failure yet? Seems like a weak criterion for justifying continued investment. That criterion would apply to every active biotech. Most companies liquidate right after proven failure.